FELLOWS DAVID A
Insider CIK 1041126 · NITE Chief Executive Officer, Director · TERN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 8,183 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 32,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 45,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 32,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 22,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 28,475 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 32,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 2,828 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 18,650 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2026-02-01 | 2026-02-02 | 2,828 | — | $0 | 2,828 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-02-01 | 2025-02-03 | 18,650 | — | $0 | 18,650 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-07-01 | 2024-07-02 | 8,183 | — | $0 | 8,183 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-06-10 | 2024-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2022-06-16 | 2022-06-21 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2021-09-28 | 2021-09-30 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer deriv | 2019-06-07 | 2019-06-07 | 271,100 | $10.76 | $2.92M | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer deriv | 2019-06-07 | 2019-06-07 | 220,000 | $11.26 | $2.48M | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer | 2019-06-07 | 2019-06-07 | 617,090 | $25.50 | $15.74M | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | S Sale | 2019-04-01 | 2019-04-03 | 9,305 | $25.31 | $235.5K | 617,090 | SEC↗ |
| NITE Nightstar Therapeutics plc | A Award deriv | 2019-01-22 | 2019-01-24 | 271,100 | — | $0 | 271,100 | SEC↗ |
| NITE Nightstar Therapeutics plc | S Sale | 2019-01-07 | 2019-01-09 | 8,733 | $12.98 | $113.4K | 630,826 | SEC↗ |
| NITE Nightstar Therapeutics plc | S Sale | 2019-01-07 | 2019-03-21 | 8,733 | $12.98 | $113.4K | 626,395 | SEC↗ |